This year marks the 20th anniversary of the publica tion showing the blood pressure-lowering effects of the Dietary Approaches to Stop Hypertension (DASH) diet.
Since the creation of DASH 20 years ago, numerous trials have demonstrated that it consistently lowers blood pres sure across a diverse range of patients with hyperten sion and prehypertension.
The initial DASH trial was a 4-site, randomized con trolled feeding study. Compared with a control diet typi cal of US consumption, the DASH diet produced reduc tions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) of 5.5 and 3.0 mm Hg, respectivelywith results evident as early as 2 weeks after baseline. 1 Blood pressure changes were observed in subgroups of men, women, racial/ethnic minorities, white indi viduals, and both hypertensive and prehypertensive participants.
1 DASH was particularly effective for those with hypertension (SBP and DBP change: −10.7 and −4.7 mm Hg, respectively) and among black individuals (SBP and DBP change: −6.8 and −3.7 mm Hg, respec tively). 1 Because of this strong evidence, DASH has been a consistent part of national blood pressure and dietary guidelines since its original publication. 2 Yet adherence to DASH on a national level is poor. A decade-old analysis of data from the National Health and Nutrition Examination Survey (NHANES) showed that less than 1% of the US population was fully adherent to DASH in 1988 to 2004, and only 20% met half of the recom mended levels of nutrients in DASH. 3 Analyses using more recent NHANES data from 2007 to 2012 showed simi larly poor adherence; the average DASH adherence score was 2.6 of a possible 9. 4 The public health significance of poor DASH adherence cannot be overstated. Of the 80 million individuals in the United States with hyperten sion, only half have controlled blood pressure. 5 Hyper tension is a primary risk factor for heart disease and stroke, 2 of the leading causes of death in the United States. A major public health challenge continues to be the broad dissemination and translation of DASH.
Achieving this goal first requires understanding the potential determinants of poor DASH adherence. At the environmental level, poor DASH adherence may be attributed to the current US food environment. Energydense, nutrient-deficient foods are highly accessible and inexpensive. Fruits and vegetables tend to be more expensive than other foods that can be purchased at fast-food restaurants. This is particularly true for lowincome individuals who may reside in areas where DASH foods are less accessible. Despite these barriers, research has shown that DASH can be adopted at low cost and among low-income individuals 6 ; foods such as dried beans or frozen vegetables are inexpensive and DASH accordant. Changing the food environment is a challenging task that will require changes at the com munity and policy levels. In the meantime, to improve adoption of DASH, efforts should focus on how indi viduals can work within their environments to improve their diets.
At the clinical level, primary care clinicians have an opportunity to provide counseling about dietary behav iors for hypertension management. Yet clinicians con sistently report that limited time, knowledge, and per ceived efficacy are barriers to dietary counseling. Moreover, many clinicians still primarily (or exclusively) recom mend reducing sodium intake for hyper tension control. 7 The extent to which pri mary care clinicians, who are responsible for the management of most patients with hypertension, are familiar with DASH is unknown. 7 In contrast, regis tered dietitians are well suited to provide counseling. Improving reimbursement coverage for registered dietitians could improve their reach. At the individual level, innovative strategies are needed to induce sustainable behavior change. An emerging strategy to improve patient self-management is the use of digital health tools. Most US adults own a mobile phone and 77% have smartphones. 8 High rates of mobile phone and smartphone ownership extend to historically disconnected populations: rural, lowincome, and racial/ethnic minority groups. 8 Because mobile devices are almost ubiquitous, they pose a unique opportunity to reach the highest-risk populations. Many apps and devices are available in the marketplace that ex plore how best to provide data that can be useful for lifestyle change and patient self-management. Yet a limited number of tools are truly evidence based. Some investigators have developed evidencebased apps that are effective and promote high engagement. For instance, Burke et al 9 found that a digital weight loss intervention was superior in both selfmonitoring engagement and weight loss compared with a nondigital approach. However, these research-based
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programs do not have the same reach as commercial products. It may be that researchers need to investigate how to integrate evidencebased approaches into the industry's publicly available tools to accel erate translation and heighten effectiveness. In the case of DASH and digital approaches to health, research findings have not penetrated the commercial market. This is because few research studies have ex amined how to best deliver DASH through digital health tools. To truly disseminate DASH will require better understanding about how to har ness tools that almost all people in the United States already have in their pocket right now. The DASH diet represents a potentially affordable and scal able intervention that could almost immediately produce consid erable improvements in population health. However, innovative strategies are necessary to determine how best to minimize the barriers to its widespread dissemination. The potential benefits of promoting DASH are substantial. As a study from 2003 suggested, if individuals with hypertension were fully adherent to DASH, an estimated 400 000 cardiovascular disease events could be pre vented over 10 years. 10 This may be an overestimate given the reduction in cardiovascular disease events that has occurred dur ing the past 14 years. Nevertheless, considering heart disease's long-standing position as the leading cause of death in the United States, it is essential to continue efforts to improve populationwide adoption of DASH. Role of the Funder/Sponsor: The funder had no role in the preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.
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